BioProcess Online

When a global crisis or other demand calls for rapid mobilization, process equipment designed to be modular, multipurpose, and single-use all help with rapid scale-up. By @TFFPharma #modularmanufacturing #mobilemanufacturing #vaccinemanufacturing bioprocessonline.com/doc/modularity…

#BusinessOfBiotech #podcast is brought to you by @BioProcessOL in partnership with @Cytiva. Check out this week’s episode featuring @UmojaBiopharma CEO David Fontana. #SolidTumors #oncology #cartcell #biopharma #SolidTumors #InVivo #CellTherapies bioprocessonline.com/doc/in-vivo-ca…

There are more than 260 genes known to cause inherited retinal diseases, and @OpusGenetics’ discovery and development work are leaving none of those stones unturned. Featuring Ben Yerxa #retinaldisease #biopharma #genetherapy #venturephilanthropy bioprocessonline.com/doc/venture-ph…

Particles in parenteral products are a major cause of product recalls, and appropriate risk management from visible particles is vital. By @Biophorum #biopharma #parenteralproducts #drugmanufacturing #injectabledrugs #biologics bioprocessonline.com/doc/a-methodol…

In #FDAGuidance, “#nanomedicine” refers to a drug product that contains at least one component with a dimension in the size range of approximately 1 nanometer (nm) up to 100 nm. Focus of the guidance is on a risk-based regulatory strategy. bioprocessonline.com/doc/fda-releas…

#BusinessOfBiotech #podcast is brought to you by Bioprocess Online in partnership with @Cytiva. Check out this week’s episode featuring Nutcracker Therapeutics’ Chief Business Officer, Dr. Geoff Nosrati. #RNATherapeutics #RNA #biopharmaceutical bioprocessonline.com/doc/rna-based-…

When a global crisis or other demand calls for rapid mobilization, process equipment designed to be modular, multipurpose, and single-use all help with rapid scale-up. By @TFFPharma #modularmanufacturing #mobilemanufacturing #vaccinemanufacturing bioprocessonline.com/doc/modularity…

Computer-aided 3D modeling enables quick assessment of previously undiscovered protein binding sites and helps scientists at @GainThera marry them to the correct therapeutic molecules. Find out how. bioprocessonline.com/doc/computatio…

#BusinessOfBiotech #podcast is brought to you by @BioProcessOL in partnership with @Cytiva. Check out this week’s episode featuring @UmojaBiopharma CEO David Fontana. #SolidTumors #oncology #cartcell #biopharma #SolidTumors #InVivo #CellTherapies bioprocessonline.com/doc/in-vivo-ca…

It is astonishing how often pharmas & biotechs commit similar or even the same #GMP mistakes — in (almost) always the same places. Here are two of the most common pitfalls to avoid: inadequate handling of deviations & inadequate handling of changes. bioprocessonline.com/doc/frequent-d…

We have entered a new age in #biologics development, which is undergoing a technological revolution with an increasing focus on software-dependent and data-driven results. By @itiscolossal #biologics #drugdiscovery #computationalscience bioprocessonline.com/doc/biology-me…

There are more than 260 genes known to cause inherited retinal diseases, and @OpusGenetics’ discovery and development work are leaving none of those stones unturned. Featuring Ben Yerxa #retinaldisease #biopharma #genetherapy #venturephilanthropy bioprocessonline.com/doc/venture-ph…

@AviadoBio is building a pipeline of investigational gene therapies for neurodegenerative diseases. Its lead preclinical candidate is AVB-101 for GRN frontotemporal dementia, an intra-thalamic gene supplementation therapy. #entrepreneur #womeninbio bioprocessonline.com/doc/from-sales…

Why are #RNABasedTherapeutics seeing more patent activity now, and how should biotech companies mitigate patent risks? Attorneys from @NGE_Law share their insights. bioprocessonline.com/doc/the-expand…

You read, watch, listen, travel to conferences & events, and learn from all of it. But none of those is the leading information source for those seeking it. What medium do most biopharma leaders seek when it’s learning they’re yearning for? Conversation. bioprocessonline.com/doc/where-biot…

On #BusinessOfBiotech #podcast, @AkariTX's @RachelleJ7k discusses the redeeming qualities of #tick saliva and how her company is putting it to work to treat rare but deadly severe hematopoietic stem cell transplant-related thrombotic microangiopathy. bioprocessonline.com/doc/tick-deriv…

Particles in parenteral products are a major cause of product recalls, and appropriate risk management from visible particles is vital. By @Biophorum #biopharma #parenteralproducts #drugmanufacturing #injectabledrugs #biologics bioprocessonline.com/doc/a-methodol…

When a global crisis or other demand calls for rapid mobilization, process equipment designed to be modular, multipurpose, and single-use all help with rapid scale-up. By @TFFPharma #modularmanufacturing #mobilemanufacturing #vaccinemanufacturing bioprocessonline.com/doc/modularity…

In #FDAGuidance, “#nanomedicine” refers to a drug product that contains at least one component with a dimension in the size range of approximately 1 nanometer (nm) up to 100 nm. Focus of the guidance is on a risk-based regulatory strategy. bioprocessonline.com/doc/fda-releas…

#BusinessOfBiotech #podcast is brought to you by Bioprocess Online in partnership with @Cytiva. Check out this week’s episode featuring Nutcracker Therapeutics’ Chief Business Officer, Dr. Geoff Nosrati. #RNATherapeutics #RNA #biopharmaceutical bioprocessonline.com/doc/rna-based-…